Novartis to uphold generic drug supply despite surging energy costs
The generic drugmakers’ association in Europe last month warned that production of some medicines may have to be stopped because…
Author
Biogen raises annual profit forecast for second straight quarter
Data on the drug has been promising and Biogen and Eisai are expected to file for a US approval soon with a decision expected in…
US FDA authorises Novavax’s COVID vaccine as booster for adults
The regulator's decision is in addition to the earlier clearance for the vaccine as a primary two-shot regimen for those aged 12…
EMA recommends Moderna’s updated Omicron-tailored vaccine
The agency also authorised Pfizer-BioNTech's and Moderna's vaccines for children as young six months
Merck under formal investigation in France over thyroid drug
The ruling by a judge in the French city of Marseille did not concern in any way the new formula for the Levothyrox product, but…
Moderna says Omicron booster response stays high through three months
The US has given the go-ahead for booster vaccines that target the currently circulating BA.4 and BA.5 subvariants of Omicron
Q3 results: Johnson & Johnson beats estimates on demand for cancer drug
The company said it expects some impact of inflation to ease next year but higher costs of inventory manufactured in 2022 could…
US health regulator extends review of Biogen’s ALS drug
Biogen said it had submitted responses to the FDA's information requests, which the agency said would require additional time for…
US Supreme Court rebuffs Novartis, allows generic versions of MS drug
Novartis had asked the justices to suspend a lower court's ruling that lifted a ban on generic versions of Gilenya, the…
Japan’s Fujifilm stops work on Avigan as COVID drug
In March, Fujifilm had cut short enrolment in a phase-III trial, saying the emergence of the Omicron variant made it tough to…